Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,648,832
  • Shares Outstanding, K 5,671,455
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 17,697 M
  • EBITDA $ 24,710 M
  • 60-Month Beta 0.61
  • Price/Sales 2.35
  • Price/Cash Flow 6.03
  • Price/Book 1.68

Options Overview Details

View History
  • Implied Volatility 24.41% ( +0.25%)
  • Historical Volatility 18.05%
  • IV Percentile 45%
  • IV Rank 43.04%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.22
  • Today's Volume 6,357
  • Volume Avg (30-Day) 151,475
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 3,174,255
  • Open Int (30-Day) 3,027,223

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 6
  • High Estimate 0.81
  • Low Estimate 0.54
  • Prior Year 0.82
  • Growth Rate Est. (year over year) -18.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.50 +2.33%
on 03/14/25
27.24 -4.22%
on 03/10/25
+0.19 (+0.73%)
since 02/20/25
3-Month
25.17 +3.66%
on 02/12/25
27.57 -5.37%
on 01/07/25
-0.27 (-1.02%)
since 12/20/24
52-Week
24.48 +6.58%
on 11/15/24
31.54 -17.28%
on 07/30/24
-1.61 (-5.81%)
since 03/20/24

Most Recent Stories

More News
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon, or approximately...

JNJ : 163.11 (+0.07%)
HLN : 10.40 (+0.29%)
GSK : 39.54 (-0.03%)
PFE : 26.24 (+0.11%)
3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE) . The pharmaceutical giant isn't as risky an investment as it may appear to be. Its financials...

PFE : 26.24 (+0.11%)
2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (NYSE: PFE) and Bristol...

PFE : 26.24 (+0.11%)
BMY : 61.01 (+1.55%)
1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade

Investor enthusiasm hit a fever pitch following the 2024 election, but took a punch to the gut recently. Market indexes have been falling as investors are beginning to assume President Trump will make...

TSLA : 235.97 (+0.05%)
$SPX : 5,673.11 (-0.04%)
PFE : 26.24 (+0.11%)
This Unstoppable Biotech Stock Just Became an Even Better Buy

Last year, Summit Therapeutics (NASDAQ: SMMT) was one of the stars of the biotech industry. The company's shares soared following a significant clinical win. Summit's market capitalization of $15.3 billion...

SMMT : 19.99 (-0.60%)
PFE : 26.24 (+0.11%)
3 Dividend Stocks to Buy for Reliable Passive Income

You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of Retirement and Disability Policy says Social Security's funds might run out by 2037,...

CVX : 164.66 (+0.37%)
ABBV : 212.25 (+0.05%)
PFE : 26.24 (+0.11%)
Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25.Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales performance...

MRK : 94.94 (+0.98%)
MRNA : 33.57 (+0.75%)
GSK : 39.54 (-0.03%)
PFE : 26.24 (+0.11%)
Pfizer's IXIFI® will be available in Canada as of April 1, 2025

/CNW/ - Pfizer Canada is pleased to announce that IXIFI® (infliximab for injection) will be available in Canada as of April 1. IXIFI® is a biosimilar to...

PFE : 26.24 (+0.11%)
3 Value Stocks in the Doghouse

3 Value Stocks in the Doghouse

ACEL : 10.13 (+0.40%)
PFE : 26.24 (+0.11%)
CXT : 54.81 (-0.94%)
Moderna Stock: Is MRNA Underperforming the Healthcare Sector?

As Moderna has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

XLV : 147.46 (+0.37%)
NVAX : 7.82 (-1.14%)
MRNA : 33.57 (+0.75%)
PFE : 26.24 (+0.11%)
BNTX : 99.48 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 26.87
2nd Resistance Point 26.68
1st Resistance Point 26.45
Last Price 26.24
1st Support Level 26.03
2nd Support Level 25.84
3rd Support Level 25.61

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 26.24
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar